Cargando…
Plasma Biomarkers of Angiogenesis Related to Small Vessel Brain Disease in SPRINT
Meta-analyses incorporating the Systolic Blood Pressure Intervention Trial (SPRINT) have shown a reduced incidence of dementia with blood pressure lowering. However, mechanistic explanations for this effect are lacking, apart from slowed progression of cerebral white matter lesions (WML). Here we ex...
Autores principales: | Pajewski, Nicholas, Elahi, Fanny, Ix, Joachim, Nasrallah, Ilya, Hinman, Jason, Launer, Lenore, Williamson, Jeff, Wilcock, Donna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680928/ http://dx.doi.org/10.1093/geroni/igab046.2517 |
Ejemplares similares
-
Association of Intensive vs Standard Blood Pressure Control With Regional Changes in Cerebral Small Vessel Disease Biomarkers: Post Hoc Secondary Analysis of the SPRINT MIND Randomized Clinical Trial
por: Rashid, Tanweer, et al.
Publicado: (2023) -
Clinical trials in vascular cognitive impairment following SPRINT-MIND: An international perspective
por: Elahi, Fanny M., et al.
Publicado: (2023) -
The Association between the Montreal Cognitive Assessment and Functional Activity Questionnaire in the Systolic Blood Pressure Intervention Trial (SPRINT)
por: Still, Carolyn H, et al.
Publicado: (2018) -
Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial
por: Ghazi, Lama, et al.
Publicado: (2023) -
Intensive Systolic Blood Pressure Treatment Remodels Brain Perivascular Spaces: A Secondary Analysis of SPRINT
por: Kern, Kyle C., et al.
Publicado: (2023)